Veterinary Biologics Market
Market Insights on Veterinary Biologics covering sales outlook, demand forecast & up-to-date key trends
Veterinary Biologics Market By Product, Animal, Distribution Channel & Region - Forecast 2022 - 2029
Veterinary Biologics Market Snapshot (2022-2029)
[232 Pages Report] The global veterinary biologics market is estimated to be US$ 11.4 Bn in 2022 and is expected to reach US$ 18.2 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey.
Veterinary Biologics Market Outlook:
|
Data Points |
Market Insights |
|
Market Value 2021 |
USD 10.6 Bn |
|
Market Value 2029 |
USD 18.2 Bn |
|
CAGR 2022-2029 |
6.9% |
|
Key Players |
The key players are Elanco Animal Health, Ceva, Phibro Animal Health Corporation, Boehringer Ingelheim, Zoetis Inc., Merck & Co., Inc., Virbac, Hester Biosciences Limited, Colorado Serum Company, Addison Biological Laboratory, Inc., American Animal Health, Inc., HIPRA, Bimeda Inc. (Texas Vet Lab, Inc.) |
|
Share of Top 5 Countries |
55.7% |
Growing demand for processed food items, increasing incidence of foodborne and zoonotic diseases, increasing awareness of pet health in developed and developing countries, improving adoption of inducing “herd immunity” in smaller animals are primary factors boosting growth of the veterinary biologics market.
Moreover, the veterinary healthcare industry is seeing demand for protozoan parasitic vaccines from countries in various regions. All these factors are expected to drive the market growth in forecast period.
Veterinary biologics market holds nearly 36.3% market value share of the US$ 29.2 Bn veterinary medicine market in 2021. In addition, manufacturers in the veterinary biologics market take comprehensive efforts to establish direct customer relations in order to enhance their relationship and trust which leads to the growth of veterinary biologics market.
Global animal production has reduced by 15%–20% annually, mainly due to rising incidence of foodborne and zoonotic diseases. With growing awareness about zoonotic diseases such as brucellosis, bird flu and swine flu, farm owners are increasingly inclined towards proper care of livestock through effective vaccination.
For instances, According to the European Food Safety Authority (EFSA), around 320,000 cases of foodborne and zoonotic diseases are reported each year in the European Union. Campylobacteriosis was the most commonly observed zoonosis in animals, which affected 220,209 people in the EU, due to consumption of infected broiler meat.
Driven by this, sales of veterinary biologics are expected to rise at a 6.9% CAGR through 2029.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1 – 2021 |
6.99% |
|
H1 – 2022 Projected |
6.91% |
|
H1 – 2022 Outlook |
6.81% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change– H1, 2022 (O) – H1, 2021 |
(-) 18 ↓ |
According to Future Market Insights’ Analysis, the global veterinary biologics market observed a reduced change in the Basis Point Share (BPS) by nearly 18 BPS units in H1- 2022(O) as compared to H1-2021.
This was mostly attributable to breakthroughs in veterinary cell culture, and the introduction of spontaneous animal disease models, which can have more variability and so require more time to examine. H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 10 BPS.
The key factor boosting the demand for veterinary biologics is the approval of biological medicinal products for marketing in veterinary use by the EMA.
Additionally, as the market is subject to changes influenced by macroeconomic and industrial factors, the growth of the veterinary biologics market is expected to be influenced by devised alternative methods for control of infectious agents, production of thermostable vaccines for veterinary use, and increasing funding for critical research needs for safe development of veterinary biologics.
Moreover, with the observed increase in the rate of affected companion animals after exposure to diseases from humans, and proposed and documented ethical review of clinical studies by a structured review committee, the market is expected to witness a positive shift in terms of value over the forecasted years.
2014-2021 Veterinary Biologics Market Demand Outlook Compared To 2022-2029 Forecast
Sales of Veterinary Biologics grew at a CAGR of 6.5% between 2014 and 2021.
The primary factors boosting the veterinary biologics market growth are increasing awareness of pet health, rising adoption rates and improving adoption of inducing “herd immunity” in smaller animals.
Rising awareness of pet health and growing incidence of infectious diseases among pets is projected to fuel revenues of the market. In this regard, it has been estimated that even in developed nations, the proportion of vaccinated companion animals varies between 30% and 50% only. This proportion is as less as 10%-15% in developing countries. However, residents in developed countries are ready to spend money to ensure better health of their pets.
In addition rising demand for pet insurance in developed economies is an ongoing trend. It has been projected that not more than 1% of pet dogs in the U.S. have insurance cover. Considering this, FMI expects the global veterinary biologics market to grow at a CAGR of 6.9% through 2029.
Which Factors Are Restraining Demand For Veterinary Biologics?
Risk from compounding therapy failure and gaps in epidemiological knowledge/ data availability are major restraining factor.
FDA reports that compounded animal drug formulations can pose serious complications to animal health. This may be attributed to factors including errors in compounded drug preparations, inappropriate amount of active ingredient, chemical and physical instability, and deficiency of bioavailability in the target patient.
According to the report, the compounded form of the drug contained 70 times the concentration of the FDA-approved drug, leading to the death of 2 horses and adverse reactions in 11 others. The other study conducted in Florida reported the death of 21 Polo horses from a 10 fold overdose of a selenium compound.
There is a large gap in understanding the epidemiology of veterinary diseases due to differences in disease patterns. A typical example is one for the Newcastle Disease for poultry, and the dearth of epidemiological knowledge for it created serious economic losses in the international poultry trade.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-Wise Insights
What Makes the U.S. a Large Market for Veterinary Biologics?
The U.S. is estimated to account for around 87.1% of the North America veterinary biologics market in 2022.
Rebound of economic prosperity in the developed markets has led to an increased demand for processed and healthy meat products. This fuels demand for effective vaccination of livestock, in nations such as U.S. Increasing consumer health awareness leads to rising consumer preference for lean white meat and fish over red meat. This is expected to drive growth of the poultry and aquaculture segment.
The animal health industry has a high impact economically and a large social contribution. Keeping animals healthy also helps in keeping humans healthy, which is further expected to drive demand for veterinary biologics over the forecast period.
This involves 850 prominent scientists, physicians, and veterinarians worldwide. Devising complementary and harmonized approaches to understand disease transmission mechanisms along with protection and persistence could help in more rational design of veterinary vaccines. This could help in better tackling emerging and remerging infections – 70% of which are vector-borne or chronic in nature. All these can drive the demand in U.S market
Why is Germany Considered a Lucrative Veterinary Biologics Market?
Germany is estimated to grow with CAGR 7.2% in the veterinary biologics market in Europe in 2022.
Growing awareness amongst the population regarding animal diseases, rise in the adoption of animal health facilities in Europe and healthcare scheme for companion insurance, which is applied to surge the efficiency of animal healthcare systems in Germany is expected to drive the market growth.
What are the Factors Fueling the Demand for Veterinary Biologics in U.K?
The veterinary biologics market in U.K is estimated to be worth US$ 644.0 Mn in 2022 in the global market.
U.K’s greater attention is on invention on product used in treatment of zoonotic diseases coupled with developments in biotechnology, which is expected to create a favorable platform for development of veterinary vaccines in high-income economies.
These techniques include next-generation sequencing, synthetic biology, and systems biology. Continued investments in multi-disciplinary vaccinology research could improve vaccine development efficiency, and shorten time-to-market for new veterinary vaccines.
Also, favorable pet insurance help in rise the adoption of pets in U.K that helps the growth of the market in this region.
How will the Veterinary Biologics Market Expand across India?
Demand for veterinary biologics in India is expected to rise at around 7.7% CAGR over the forecast period.
The increasing prevalence as well as incidence of zoonotic disease are major public health concerns. Zoonotic diseases are transmitted by animals to humans. More than 70% of human infectious diseases are caused by pathogens shared by wild and domestic animals.
The major pathogens and diseases associated with zoonotic are Ebola hemorrhagic fever, anthrax, rift valley fever, brucellosis, Chagas disease, an influenza, severe acute respiratory syndrome (SARS), leptospirosis, cysticercoids and echinococcosis, and toxoplasmas.
Many foodborne zoonotic diseases such as bovine tuberculosis, brucellosis, salmonellosis, and some helminth infections especially occur in low-income and middle-income countries like India creating high risk related to foodborne disease.
Category-Wise Insights
Demand for Vaccines continue gaining Traction
By Product, Vaccines are anticipated to hold the maximum share of 91.4% in 2022, expanding at rate of nearly 6.5% during the forecast period.
Unification of veterinary drugs/biologics research along with research in human medicine is being undertaken through leading nodal healthcare agencies such as the American Medical Association, American Veterinary Medical Association, the American Society of Tropical Medicine and Hygiene, the CDC, the USDA, and the U.S. National Environmental Health Association (NEHA) for development of vaccines. This is anticipated to surge their adoption of vaccines and drive the demand.
Why Livestock will hold the most of the market share?
By Animal Type, Livestock is leading the market and is projected to account for 51.7% of the total market revenue share in 2022.
Increasing demand for the processed animal origin food, high adoption of dairy product and also USDA’s classification of pork, veal, beef, and lamb (mutton) as livestock, and all livestock are all the prime factors generating significant incremental opportunity for livestock animal segment growth in veterinary biologics market.
Why Veterinary Clinics Projected Maximum Growth in the Veterinary Biologics Market?
By distribution channel, veterinary clinics is anticipated to hold the maximum share of 41.3% in 2022, expanding at rapid rate of 7.3% CAGR during the forecast period.
The growing adoption of pet and increasing number of walk-in patient in hospitals is leading to the growing market share of veterinary clinics. Veterinary clinics is the place where all primary care is taken in clinics so most of pet care is done there. Hence an increased share is seen from clinics.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Competitive Landscape
Companies operating in the veterinary biologics market are competitive by nature, with a presence of few players. These players are involved in a number of strategic alliances. The product launch and acquisition accelerates the manufacturer’s strategy to capitalize on the market share and capture the significant share of market. Some of the recent instances include:
- In July 2020 – Zoetis acquired Benchmark Holdings, PLC, as a strategic addition to its pharma business, which develops and commercializes fish vaccines and offers services in vaccination and diagnostics for aquaculture.
- In March 2021, Elanco Animal Health company launched its newest innovation for Cats, Elura™ (capromorelin oral solution), for chronic kidney diseases to U.S. veterinarians.
Scope Of The Report
|
Attribute |
Details |
|
Forecast Period |
2014-2021 |
|
Historical Data Available for |
2022-2029 |
|
Market Analysis |
USD Billion for Value |
|
Key Countries Covered |
US, Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, BENELUX, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Australia, New Zealand, GCC Countries, South Africa, Turkey |
|
Key Segments Covered |
Product, Animal, Distribution Channel and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Veterinary Biologics Market By Category
By Product
- Vaccines
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
- Bacterial Extracts
- Monoclonal Antibody
- Immunomodulatory
- Cytokines
- Others
- Allergenic Extracts
By Animal
- Companion Animals
- Canine
- Avian
- Feline
- Livestock
- Aquatic
- Bovine
- Porcine
- Ovine/Caprine
- Poultry
- Equine
By Distribution Channel
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Retail Pharmacies
By Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Frequently Asked Questions
How much is the Veterinary Biologics market currently worth?
The global veterinary biologics market is estimated to be US$ 11.4 Bn in 2022 and is set to expand 1.6X over the forecasted years owing to the rising number of pet adoption and increasing incidence of foodborne and zoonotic diseases.
What was last 7 year market CAGR?
The sales of veterinary biologics in the market have grown at a CAGR of nearly 6.5% between 2014 and 2021.
What will be demand outlook/sales forecast of Veterinary Biologics market?
The veterinary biologics market is expected to reach US$ 18.2 Bn by the end of 2029 with sales revenue expected to register CAGR of 6.9% over the forecast period.
Which is the most lucrative market for Veterinary Biologics market?
North America currently holds the largest market share in the veterinary biologics. U.S. being the leading contributor with a market value over US$ 3.1 Bn in 2022.
At what percentage Veterinary Biologics market is expected to register growth in Europe?
Demand of veterinary biologics market is expected to register growth in Europe at rate of 6.7% CAGR during the forecast period.
How likely is the Veterinary Biologics market to grow in China?
The veterinary biologics in China is likely to observe growth with an impressive CAGR of 8.1% during the forecast period. The market in China is driven by the increasing awareness of pet health in china and growing technological advancements in biologics.
What are key trends driving sales of Veterinary Biologics?
Acquisitions by big players, enhancing direct customer interactions, growing focus on developing protozoan parasitic vaccines, smaller players- limited room for growth and adoption of pet insurance in matured markets are key trends driving sales of veterinary biologics market across the globe.
What are the key market statistics in South Korea and Japan?
Japan’s veterinary biologics market is offering lucrative growth opportunities and is expected to exhibit healthy growth of 6.8% CAGR during the forecast period. South Korea market expected to exhibit healthy growth of 6.3% CAGR during the forecast period.
What are the top 5 countries driving demand for Veterinary Biologics market?
U.S., China, Italy, U.K, and Germany are the top 5 countries that are driving the demand for Veterinary Biologics market.
Which are leading companies of Veterinary Biologics market?
Leading companies of veterinary biologics are Elanco Animal Health, Ceva, Phibro Animal Health Corporation, Boehringer Ingelheim, Zoetis Inc., Merck & Co., Inc., Virbac, Hester Biosciences Limited, Colorado Serum Company, Addison Biological Laboratory, Inc., American Animal Health, Inc., HIPRA, Bimeda Inc. (Texas Vet Lab, Inc.)
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Key Market Trends 3.1. Key Trends Impacting the Market 4. Key Success Factors 4.1. Regulatory Scenario 5. Global Veterinary Biologics Market Demand (in Value or Size in US$ Mn) Analysis 2014-2021and Forecast, 2022-2029 5.1. Historical Market Value (US$ Mn) Analysis, 2014-2021 5.2. Current and Future Market Value (US$ Mn) Projections, 2022-2029 5.2.1. Y-o-Y Growth Trend Analysis 5.2.2. Absolute $ Opportunity Analysis 6. Market Background 6.1. Macro-Economic Factors 6.2. Forecast Factors - Relevance & Impact 6.3. Market Dynamics 6.3.1. Drivers 6.3.2. Restraints 6.3.3. Opportunity Analysis 7. Global Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029, by Product 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Mn) Analysis By Product, 2014 - 2021 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022 - 2029 7.3.1. Vaccines 7.3.1.1. Attenuated Live Vaccines 7.3.1.2. Conjugate Vaccines 7.3.1.3. Inactivated Vaccines 7.3.1.4. Subunit Vaccines 7.3.1.5. Toxoid Vaccines 7.3.1.6. DNA Vaccines 7.3.1.7. Recombinant Vaccines 7.3.2. Bacterial Extracts 7.3.3. Monoclonal Antibody 7.3.4. Immunomodulators 7.3.4.1. Cytokines 7.3.4.2. Others 7.3.5. Allergenic Extracts 7.4. Market Attractiveness Analysis By Product 8. Global Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029, by Animal 8.1. Introduction / Key Findings 8.2. Historical Veterinary Biologics Market Size (US$ Mn) Analysis By Animal, 2014 - 2021 8.3. Current and Future Veterinary Biologics Market Size (US$ Mn) Analysis By Animal, 2022 - 2029 8.3.1. Companion Animals 8.3.1.1. Canine 8.3.1.2. Avian 8.3.1.3. Feline 8.3.2. Livestock Animals 8.3.2.1. Aquatic 8.3.2.2. Bovine 8.3.2.3. Porcine 8.3.2.4. Ovine/Caprine 8.3.2.5. Poultry 8.3.3. Equine 8.4. Market Attractiveness Analysis of Antitoxins Market By Animal 9. Global Veterinary Biologics - Cytokines Market Analysis 2014-2021 and Forecast 2022-2029, by Animal 9.1. Historical Cytokines Market Size (US$ Mn) Analysis By Animal, 2014 - 2021 9.2. Current and Future Cytokines Market Size (US$ Mn) Analysis By Animal, 2022 - 2029 9.2.1. Companion Animals 9.2.1.1. Canine 9.2.1.2. Avian 9.2.1.3. Feline 9.2.2. Livestock Animals 9.2.2.1. Aquatic 9.2.2.2. Bovine 9.2.2.3. Porcine 9.2.2.4. Ovine/Caprine 9.2.2.5. Poultry 9.2.3. Equine 10. Global Veterinary Biologics - Other Immunomodulatory Biologics Market Analysis 2014-2021 and Forecast 2022-2029, by Animal 10.1. Historical Other Immuno-Suppressing Agents Market Size (US$ Mn) Analysis By Animal, 2014 - 2021 10.2. Current and Future Other Immuno-Suppressing Agents Market Size (US$ Mn) Analysis By Animal, 2022 - 2029 10.2.1. Companion Animals 10.2.1.1. Canine 10.2.1.2. Avian 10.2.1.3. Feline 10.2.2. Livestock Animals 10.2.2.1. Aquatic 10.2.2.2. Bovine 10.2.2.3. Porcine 10.2.2.4. Ovine/Caprine 10.2.2.5. Poultry 10.2.3. Equine 11. Global Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029, By Distribution Channel 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 - 2021 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2022 – 2029 11.3.1. Veterinary Clinics 11.3.2. Veterinary Hospitals 11.3.3. Veterinary Research Institutes 11.3.4. Retail Pharmacies 11.4. Market Attractiveness Analysis By Distribution Channel 12. Global Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029, By Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Animal, 2014 - 2021 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022 - 2029 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. South Asia 12.3.5. East Asia 12.3.6. Oceania 12.3.7. Middle East & Africa 12.4. Market Attractiveness Analysis By Region 13. North America Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Product 13.3.3. By Animal 13.3.4. By Distribution Channel 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By Animal 13.4.4. By Distribution Channel 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 - 2021 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022 - 2029 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Rest of Latin America 14.3.2. By Product 14.3.3. By Animal 14.3.4. By Distribution Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Animal 14.4.4. By Distribution Channel 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029 15.1. Introduction 15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021 15.3. Market Size (US$ Mn) and By Market Taxonomy, 2022 - 2029 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. BENELUX 15.3.1.7. Russia 15.3.1.8. Rest of Europe 15.3.2. By Product 15.3.3. By Animal 15.3.4. By Distribution Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Animal 15.4.4. By Distribution Channel 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029 16.1. Introduction 16.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021 16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Product 16.3.3. By Animal 16.3.4. By Distribution Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Animal 16.4.4. By Distribution Channel 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029 17.1. Introduction 17.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021 17.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Product 17.3.3. By Animal 17.3.4. By Distribution Channel 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Animal 17.4.4. By Distribution Channel 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029 18.1. Introduction 18.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021 18.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product 18.3.3. By Animal 18.3.4. By Distribution Channel 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Animal 18.4.4. By Distribution Channel 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. MEA Veterinary Biologics Market Analysis 2014-2021 and Forecast 2022-2029 19.1. Introduction 19.2. Pricing Analysis 19.3. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2021 19.4. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2022 - 2029 19.4.1. By Country 19.4.1.1. GCC Countries 19.4.1.2. Turkey 19.4.1.3. Northern Africa 19.4.1.4. South Africa 19.4.1.5. Rest of MEA 19.4.2. By Product 19.4.3. By Animal 19.4.4. By Distribution Channel 19.5. Market Attractiveness Analysis 19.5.1. By Country 19.5.2. By Product 19.5.3. By Animal 19.5.4. By Distribution Channel 19.6. Key Market Participants - Intensity Mapping 19.7. Drivers and Restraints - Impact Analysis 20. Emerging Countries Veterinary Biologics Market Analysis 2022 & 2029 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. China Veterinary Biologics Market Analysis 20.2.1. Introduction 20.2.2. PEST Analysis 20.2.3. Market Value Proportion Analysis by Market Taxonomy 20.2.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 20.2.4.1. By Product 20.2.4.2. By Animal 20.2.4.3. By Distribution Channel 20.3. India Veterinary Biologics Market Analysis 20.3.1. Introduction 20.3.2. PEST Analysis 20.3.3. Market Value Proportion Analysis by Market Taxonomy 20.3.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 20.3.4.1. By Product 20.3.4.2. By Animal 20.3.4.3. By Distribution Channel 20.4. Brazil Veterinary Biologics Market Analysis 20.4.1. Introduction 20.4.2. PEST Analysis 20.4.3. Market Value Proportion Analysis by Market Taxonomy 20.4.4. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy 20.4.4.1. By Product 20.4.4.2. By Animal 20.4.4.3. By Distribution Channel 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. Product foot print by Players 21.4.2. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. Elanco Animal Health 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Profitability by Market Segments (Product/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.1.5.1. Marketing Strategy 22.3.1.5.2. Product Strategy 22.3.1.5.3. Channel Strategy 22.3.2. Ceva 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Profitability by Market Segments (Product/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.2.5.1. Marketing Strategy 22.3.2.5.2. Product Strategy 22.3.2.5.3. Channel Strategy 22.3.3. Phibro Animal Health Corporation 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Profitability by Market Segments (Product/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.3.5.1. Marketing Strategy 22.3.3.5.2. Product Strategy 22.3.3.5.3. Channel Strategy 22.3.4. Boehringer Ingelheim 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Profitability by Market Segments (Product/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.4.5.1. Marketing Strategy 22.3.4.5.2. Product Strategy 22.3.4.5.3. Channel Strategy 22.3.5. Zoetis, Inc. 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Profitability by Market Segments (Product/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.5.5.1. Marketing Strategy 22.3.5.5.2. Product Strategy 22.3.5.5.3. Channel Strategy 22.3.6. Merck Animal Health 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Profitability by Market Segments (Product/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.6.5.1. Marketing Strategy 22.3.6.5.2. Product Strategy 22.3.6.5.3. Channel Strategy 22.3.7. Virbac 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Profitability by Market Segments (Product/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.7.5.1. Marketing Strategy 22.3.7.5.2. Product Strategy 22.3.7.5.3. Channel Strategy 22.3.8. Hester Biosciences Limited 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Profitability by Market Segments (Product/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.8.5.1. Marketing Strategy 22.3.8.5.2. Product Strategy 22.3.8.5.3. Channel Strategy 22.3.9. Colorado Serum Company 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Profitability by Market Segments (Product/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.9.5.1. Marketing Strategy 22.3.9.5.2. Product Strategy 22.3.9.5.3. Channel Strategy 22.3.10. Addison Biological Laboratory, Inc. 22.3.10.1. Overview 22.3.10.2. Product Portfolio 22.3.10.3. Profitability by Market Segments (Product/Channel/Region) 22.3.10.4. Sales Footprint 22.3.10.5. Strategy Overview 22.3.10.5.1. Marketing Strategy 22.3.10.5.2. Product Strategy 22.3.10.5.3. Channel Strategy 22.3.11. American Animal Health, Inc. 22.3.11.1. Overview 22.3.11.2. Product Portfolio 22.3.11.3. Profitability by Market Segments (Product/Channel/Region) 22.3.11.4. Sales Footprint 22.3.11.5. Strategy Overview 22.3.11.5.1. Marketing Strategy 22.3.11.5.2. Product Strategy 22.3.11.5.3. Channel Strategy 22.3.12. HIPRA 22.3.12.1. Overview 22.3.12.2. Product Portfolio 22.3.12.3. Profitability by Market Segments (Product/Channel/Region) 22.3.12.4. Sales Footprint 22.3.12.5. Strategy Overview 22.3.12.5.1. Marketing Strategy 22.3.12.5.2. Product Strategy 22.3.12.5.3. Channel Strategy 22.3.13. Bimeda Inc. (Texas Vet Lab, Inc.) 22.3.13.1. Overview 22.3.13.2. Product Portfolio 22.3.13.3. Profitability by Market Segments (Product/Channel/Region) 22.3.13.4. Sales Footprint 22.3.13.5. Strategy Overview 22.3.13.5.1. Marketing Strategy 22.3.13.5.2. Product Strategy 22.3.13.5.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product Table 02: Global Veterinary Cytokines Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal Table 03: Global Veterinary Other Immunomodulatory Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal Table 04: Global Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal Table 05: Global Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 06: Global Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Region Table 07: North America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country Table 08: North America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product Table 09: North America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal Table 10: North America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 11: Latin America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country Table 12: Latin America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product Table 13: Latin America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal Table 14: Latin America Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 15: Europe Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country Table 16: Europe Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product Table 17: Europe Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal Table 18: Europe Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 19: South Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country Table 20: South Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product Table 21: South Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal Table 22: South Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 23: East Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country Table 24: East Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product Table 25: East Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal Table 26: East Asia Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 27: Oceania Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country Table 28: Oceania Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product Table 29: Oceania Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal Table 30: Oceania Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 31: MEA Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Country Table 32: MEA Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product Table 33: MEA Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal Table 34: MEA Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 35: China Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product Table 36: China Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal Table 37: China Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 38: India Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product Table 39: India Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal Table 40: India Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel Table 41: Brazil Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Product Table 42: Brazil Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Animal Table 43: Brazil Veterinary Biologics Market Size (US$ Mn) Analysis 2014-2021 and Opportunity Assessment 2022-2029, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global veterinary biologics Historical Market Size and Y-o-Y, 2014-2021 Figure 02: Global veterinary biologics Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2029 Figure 03: Global veterinary biologics Market Absolute $ Opportunity, 2014–2029 Figure 04: Global Veterinary Biologics Market Share Analysis (%) By Product, 2022 & 2029 Figure 05: Global Veterinary Biologics Market Y-o-Y Growth (%) By Product, 2022–2029 Figure 06: Global Veterinary Biologics Market Attractiveness Analysis, By Product Figure 07: Global Veterinary Biologics Market Share Analysis (%) By Animal, 2022 & 2029 Figure 08: Global Veterinary Biologics Market Y-o-Y Growth (%) By Animal, 2022–2029 Figure 09: Global Veterinary Biologics Market Attractiveness Analysis, By Animal Figure 10: Global Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029 Figure 11: Global Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029 Figure 12: Global Veterinary Biologics Market Attractiveness Analysis, By Distribution Channel Figure 13: Global Veterinary Biologics Market Share Analysis (%) By Region, 2022 & 2029 Figure 14: Global Veterinary Biologics Market Y-o-Y Growth (%) By Region, 2022–2029 Figure 15: Global Veterinary Biologics Market Attractiveness Analysis, By Region Figure 16: North America Veterinary Biologics Market Size (US$ Mn), 2014-2021 Figure 17: North America Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 18: North America Veterinary Biologics Market Analysis by Country – 2022 & 2029 Figure 19: North America Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029 Figure 20: North America Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029 Figure 21: North America Veterinary Biologics Market Analysis by Product – 2022 & 2029 Figure 22: North America Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029 Figure 23: North America Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029 Figure 24: North America Veterinary Biologics Market Analysis by Animal –2022 & 2029 Figure 25: North America Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029 Figure 26: North America Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029 Figure 27: North America Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029 Figure 28: North America Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029 Figure 29: North America Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 30: Latin America Veterinary Biologics Market Size (US$ Mn), 2014-2021 Figure 31: Latin America Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 32: Latin America Veterinary Biologics Market Analysis by Country – 2022 & 2029 Figure 33: Latin America Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029 Figure 34: Latin America Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029 Figure 35: Latin America Veterinary Biologics Market Analysis by Product – 2022 & 2029 Figure 36: Latin America Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029 Figure 37: Latin America Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029 Figure 38: Latin America Veterinary Biologics Market Analysis by Animal –2022 & 2029 Figure 39: Latin America Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029 Figure 40: Latin America Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029 Figure 41: Latin America Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029 Figure 42: Latin America Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029 Figure 43: Latin America Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 44: Europe Veterinary Biologics Market Size (US$ Mn), 2014-2021 Figure 45: Europe Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 46: Europe Veterinary Biologics Market Analysis by Country – 2022 & 2029 Figure 47: Europe Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029 Figure 48: Europe Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029 Figure 49: Europe Veterinary Biologics Market Analysis by Product – 2022 & 2029 Figure 50: Europe Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029 Figure 51: Europe Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029 Figure 52: Europe Veterinary Biologics Market Analysis by Animal –2022 & 2029 Figure 53: Europe Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029 Figure 54: Europe Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029 Figure 55: Europe Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029 Figure 56: Europe Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029 Figure 57: Europe Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 58: South Asia Veterinary Biologics Market Size (US$ Mn), 2014-2021 Figure 59: South Asia Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 60: South Asia Veterinary Biologics Market Analysis by Country – 2022 & 2029 Figure 61: South Asia Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029 Figure 62: South Asia Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029 Figure 63: South Asia Veterinary Biologics Market Analysis by Product – 2022 & 2029 Figure 64: South Asia Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029 Figure 65: South Asia Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029 Figure 66: South Asia Veterinary Biologics Market Analysis by Animal –2022 & 2029 Figure 67: South Asia Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029 Figure 68: South Asia Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029 Figure 69: South Asia Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029 Figure 70: South Asia Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029 Figure 71: South Asia Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 72: East Asia Veterinary Biologics Market Size (US$ Mn), 2014-2021 Figure 73: East Asia Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 74: East Asia Veterinary Biologics Market Analysis by Country – 2022 & 2029 Figure 75: East Asia Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029 Figure 76: East Asia Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029 Figure 77: East Asia Veterinary Biologics Market Analysis by Product – 2022 & 2029 Figure 78: East Asia Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029 Figure 79: East Asia Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029 Figure 80: East Asia Veterinary Biologics Market Analysis by Animal –2022 & 2029 Figure 81: East Asia Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029 Figure 82: East Asia Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029 Figure 83: East Asia Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029 Figure 84: East Asia Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029 Figure 85: East Asia Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 86: Oceania Veterinary Biologics Market Size (US$ Mn), 2014-2021 Figure 87: Oceania Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 88: Oceania Veterinary Biologics Market Analysis by Country – 2022 & 2029 Figure 89: Oceania Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029 Figure 90: Oceania Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029 Figure 91: Oceania Veterinary Biologics Market Analysis by Product – 2022 & 2029 Figure 92: Oceania Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029 Figure 93: Oceania Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029 Figure 94: Oceania Veterinary Biologics Market Analysis by Animal –2022 & 2029 Figure 95: Oceania Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029 Figure 96: Oceania Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029 Figure 97: Oceania Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029 Figure 98: Oceania Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029 Figure 99: Oceania Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 100: MEA Veterinary Biologics Market Size (US$ Mn), 2014-2021 Figure 101: MEA Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 102: MEA Veterinary Biologics Market Analysis by Country – 2022 & 2029 Figure 103: MEA Veterinary Biologics Market Y-o-Y Growth Projections by Country, 2022-2029 Figure 104: MEA Veterinary Biologics Market Attractiveness Analysis by Country, 2022-2029 Figure 105: MEA Veterinary Biologics Market Analysis by Product – 2022 & 2029 Figure 106: MEA Veterinary Biologics Market Y-o-Y Growth Projections by Product, 2022-2029 Figure 107: MEA Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029 Figure 108: MEA Veterinary Biologics Market Analysis by Animal –2022 & 2029 Figure 109: MEA Veterinary Biologics Market Y-o-Y Growth Projections by Animal , 2022-2029 Figure 110: MEA Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029 Figure 111: MEA Veterinary Biologics Market Analysis by Distribution Channel –2022 & 2029 Figure 112: MEA Veterinary Biologics Market Y-o-Y Growth Projections by Distribution Channel, 2022-2029 Figure 113: MEA Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 114: Emerging countries Veterinary Biologics Market Size (US$ Mn) Analysis, 2022 Figure 115: Emerging countries Veterinary Biologics Market Size (US$ Mn) 2014 – 2029 Figure 116: China Veterinary Biologics Market Size (US$ Mn), 2014-2021 Figure 117: China Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 118: China Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029 Figure 119: China Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029 Figure 120: China Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 121: India Veterinary Biologics Market Size (US$ Mn), 2014-2021 Figure 122: India Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 123: India Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029 Figure 124: India Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029 Figure 125: India Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029 Figure 126: Brazil Veterinary Biologics Market Size (US$ Mn), 2014-2021 Figure 127: Brazil Veterinary Biologics Market Size (US$) & Y-o-Y Growth (%), 2022–2029 Figure 128: Brazil Veterinary Biologics Market Attractiveness Analysis by Product, 2022-2029 Figure 129: Brazil Veterinary Biologics Market Attractiveness Analysis by Animal , 2022-2029 Figure 130: Brazil Veterinary Biologics Market Attractiveness Analysis by Distribution Channel, 2022-2029
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
